William David

2.6k citations
23 papers · 2.0k · 2 hit papers · h-index 14

Impact in

  • Neurology top 1%
    • Myasthenia Gravis and Thymoma
    • Amyotrophic Lateral Sclerosis Research
    • Peripheral Neuropathies and Disorders
    • Parkinson's Disease and Spinal Disorders
  • Genetics top 5%
    • Neurogenetic and Muscular Disorders Research

Papers in

    • Amyotrophic Lateral Sclerosis Research 5
    • Myasthenia Gravis and Thymoma 3
    • Neurogenetic and Muscular Disorders Research 2

William David

22 papers receiving 1.9k citations

William David's Hit Papers

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 2017 · 622 citations
6220+4+8Years since publication200400600

Peers

William David
Comparison fields: 5 of 89
  • Neurology 1.2k
  • Genetics 406
  • Cellular and Molecular Neuroscience 254
  • Neurology 84
  • Molecular Biology 562
Replace Georgios Manousakis with:
Georgios Manousakis United States
Timothée Lenglet France
Min-Sheng Wang United States
Mieko Ogino Japan
Christopher Lindberg Sweden
Pierre Raymond Bourque Canada
David Saperstein United States
Stojan Peric Serbia
O. Dewitte Belgium
Gaetano Bernardi Italy
William David relative to Georgios Manousakis United States Georgios Manousakis's profile →
Citations per field
00.5×1.5×2.0×
Georgios Manousakis · 1×
Citations per year

Countries citing papers authored by William David

Since Specialization
Citations

This map shows the geographic impact of William David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William David more than expected).

Fields of papers citing papers by William David

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William David. The network helps show where William David may publish in the future.

Co-authors

The 25 scholars most cited alongside William David, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William David Line = papers co-authored together William David links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
Hit paper breakdown →
2017622
2
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
Hit paper breakdown →
2013536
3 2014172
4 2018108
5 2006100
6 201699
7 201997
8 200661
9 202038
10 201831
11 201727
12 201920
13 201519
14 201415
15 20159
16 20153
17 20193
18 20172
19 20061
20 20121

About William David

William David is a scholar working on Neurology, Genetics, Pharmacology, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience, having authored 23 papers that have together received 2.0k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (5 papers), Myasthenia Gravis and Thymoma (3 papers), Muscle Physiology and Disorders (2 papers), Biomedical Research and Pathophysiology (2 papers), Neurogenetic and Muscular Disorders Research (2 papers), Orthopedic Surgery and Rehabilitation (1 paper), COVID-19 epidemiological studies (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Neurology (1.2k citations), Genetics (406 citations), Cellular and Molecular Neuroscience (254 citations), Neurology (84 citations) and Molecular Biology (562 citations). William David has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Merit Cudkowicz, David Schoenfeld, Eric A. Macklin, Ericka Simpson, Stanley H. Appel, Jeffrey Rothstein, Lyle W. Ostrow, Timothy M. Miller, Patricia L. Andres and Georgios Manousakis. Their work appears in journals such as Neurology, The Lancet Neurology, Muscle & Nerve, Seminars in Neurology and Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact